! Oncolin Therapeutics: Advancing Technology to Treat Cancer
 
 
 
 
 

Agreement with M.D. Anderson providing the right to negotiate a license for five technologies relating to treatment of cancers.
National Institute of Health
Peer Reviewed National Institute of Health Grant of $179,000 to support research on thermally targeted delivery of Doxorubicin.